位置:首页 > 蛋白库 > JAK2_PONAB
JAK2_PONAB
ID   JAK2_PONAB              Reviewed;        1132 AA.
AC   Q5RB23;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 123.
DE   RecName: Full=Tyrosine-protein kinase JAK2 {ECO:0000250|UniProtKB:O60674};
DE            EC=2.7.10.2 {ECO:0000250|UniProtKB:O60674};
DE   AltName: Full=Janus kinase 2;
DE            Short=JAK-2;
GN   Name=JAK2 {ECO:0000250|UniProtKB:O60674};
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Non-receptor tyrosine kinase involved in various processes
CC       such as cell growth, development, differentiation or histone
CC       modifications. Mediates essential signaling events in both innate and
CC       adaptive immunity. In the cytoplasm, plays a pivotal role in signal
CC       transduction via its association with type I receptors such as growth
CC       hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR),
CC       thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-
CC       beta, IFN-gamma and multiple interleukins. Following ligand-binding to
CC       cell surface receptors, phosphorylates specific tyrosine residues on
CC       the cytoplasmic tails of the receptor, creating docking sites for STATs
CC       proteins. Subsequently, phosphorylates the STATs proteins once they are
CC       recruited to the receptor. Phosphorylated STATs then form homodimer or
CC       heterodimers and translocate to the nucleus to activate gene
CC       transcription. For example, cell stimulation with erythropoietin (EPO)
CC       during erythropoiesis leads to JAK2 autophosphorylation, activation,
CC       and its association with erythropoietin receptor (EPOR) that becomes
CC       phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or
CC       STAT5B) is recruited, phosphorylated and activated by JAK2. Once
CC       activated, dimerized STAT5 translocates into the nucleus and promotes
CC       the transcription of several essential genes involved in the modulation
CC       of erythropoiesis. Part of a signaling cascade that is activated by
CC       increased cellular retinol and that leads to the activation of STAT5
CC       (STAT5A or STAT5B). In addition, JAK2 mediates angiotensin-2-induced
CC       ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating
CC       CDKN1B. Cooperates with TEC through reciprocal phosphorylation to
CC       mediate cytokine-driven activation of FOS transcription. In the
CC       nucleus, plays a key role in chromatin by specifically mediating
CC       phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag
CC       that promotes exclusion of CBX5 (HP1 alpha) from chromatin.
CC       {ECO:0000250|UniProtKB:O60674}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305};
CC       Note=Mn(2+) was used in the in vitro kinase assay but Mg(2+) is likely
CC       to be the in vivo cofactor. {ECO:0000305};
CC   -!- ACTIVITY REGULATION: Regulated by autophosphorylation, can both
CC       activate or decrease activity. Heme regulates its activity by enhancing
CC       the phosphorylation on Tyr-1007 and Tyr-1008.
CC       {ECO:0000250|UniProtKB:O60674, ECO:0000250|UniProtKB:Q62120}.
CC   -!- SUBUNIT: Interacts with IL23R, SKB1 and STAM2 (By similarity).
CC       Interacts with EPOR. Interacts with LYN. Interacts with SIRPA.
CC       Interacts with SH2B1. Interacts with TEC (By similarity). Interacts
CC       with IFNGR2 (via intracellular domain) (By similarity). Interacts with
CC       LEPR (Isoform B) (By similarity). Interacts with HSP90AB1; promotes
CC       functional activation in a heat shock-dependent manner. Interacts with
CC       STRA6 (By similarity). Interacts with RHEX; this interaction occurs in
CC       a erythropoietin (EPO)-dependent manner (By similarity). Interacts with
CC       ASB2; the interaction targets JAK2 for Notch-induced proteasomal
CC       degradation (By similarity). {ECO:0000250|UniProtKB:O60674,
CC       ECO:0000250|UniProtKB:Q62120}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- DOMAIN: The N-terminal domain of JAKs mediates their interaction with
CC       cytokine/interferon/growth hormone receptors. Possesses 2 protein
CC       kinase domains. The second one probably contains the catalytic domain,
CC       while the presence of slight differences suggest a different role for
CC       protein kinase 1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated, leading to regulate its activity. Leptin
CC       promotes phosphorylation on tyrosine residues, including
CC       phosphorylation on Tyr-813. Autophosphorylation on Tyr-119 in response
CC       to EPO down-regulates its kinase activity. Autophosphorylation on Tyr-
CC       868, Tyr-966 and Tyr-972 in response to growth hormone (GH) are
CC       required for maximal kinase activity. Also phosphorylated by TEC (By
CC       similarity). Phosphorylated on tyrosine residues in response to
CC       interferon gamma signaling. Phosphorylated on tyrosine residues in
CC       response to a signaling cascade that is activated by increased cellular
CC       retinol (By similarity). {ECO:0000250|UniProtKB:O60674,
CC       ECO:0000250|UniProtKB:Q62120}.
CC   -!- PTM: Undergoes Notch-induced ubiquitination and subsequent proteasomal
CC       degradation which is mediated by ASB1 or ASB2, the substrate-
CC       recognition components of probable ECS E3 ubiquitin-protein ligase
CC       complexes. {ECO:0000250|UniProtKB:O60674}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR858835; CAH91037.1; -; mRNA.
DR   RefSeq; NP_001125600.1; NM_001132128.1.
DR   AlphaFoldDB; Q5RB23; -.
DR   SMR; Q5RB23; -.
DR   STRING; 9601.ENSPPYP00000021551; -.
DR   GeneID; 100172517; -.
DR   KEGG; pon:100172517; -.
DR   CTD; 3717; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   InParanoid; Q5RB23; -.
DR   Proteomes; UP000001595; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0035401; F:histone kinase activity (H3-Y41 specific); ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0042976; P:activation of Janus kinase activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060397; P:growth hormone receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:UniProt.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:UniProt.
DR   GO; GO:0051239; P:regulation of multicellular organismal process; IEA:UniProt.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   CDD; cd13333; FERM_C_JAK2; 1.
DR   CDD; cd05078; PTK_Jak2_rpt1; 1.
DR   CDD; cd14205; PTKc_Jak2_rpt2; 1.
DR   CDD; cd10379; SH2_Jak2; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR041155; FERM_F1.
DR   InterPro; IPR041046; FERM_F2.
DR   InterPro; IPR041381; JAK1-3/TYK2_PHL_dom.
DR   InterPro; IPR037838; JAK2_FERM_C-lobe.
DR   InterPro; IPR035860; JAK2_SH2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR035588; PTK_Jak2_rpt1.
DR   InterPro; IPR035589; PTKc_Jak2_rpt2.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR020693; Tyr_kinase_non-rcpt_Jak2.
DR   Pfam; PF18379; FERM_F1; 1.
DR   Pfam; PF18377; FERM_F2; 1.
DR   Pfam; PF17887; Jak1_Phl; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 2.
DR   Pfam; PF00017; SH2; 1.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR01825; JANUSKINASE2.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; ATP-binding; Chromatin regulator; Cytoplasm; Immunity;
KW   Innate immunity; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   SH2 domain; Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN           1..1132
FT                   /note="Tyrosine-protein kinase JAK2"
FT                   /id="PRO_0000324094"
FT   DOMAIN          37..380
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   DOMAIN          401..482
FT                   /note="SH2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          545..809
FT                   /note="Protein kinase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          849..1126
FT                   /note="Protein kinase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..239
FT                   /note="Interaction with cytokine/interferon/growth hormone
FT                   receptors"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        976
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         855..863
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         882
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         119
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         372
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         373
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         570
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
FT   MOD_RES         813
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         868
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         966
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         972
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62120"
FT   MOD_RES         1007
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
FT   MOD_RES         1008
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O60674"
SQ   SEQUENCE   1132 AA;  130704 MW;  25EA1ADCB4B2B918 CRC64;
     MGMACLTMTE MEGTSTSSIY QNGDISGNAN SMKQIDPVLL VYLYHSLGKS EADYLTFPSG
     EYVAEEICIA ASKACGITPV YHNMFALMSE TERIWYPPNH VFHIDESTRH NVLYRIRFYF
     PRWYCSGSNR AYRHGISRGA EAPLLDDFVM SYLFAQWRHD FVHGWIKVPV THETQEECLG
     MAVLDMMRIA KENDQTPLAI YNSISYKTFL PKCIRAKIQD YHILTRKRIR YRFRRFIQQF
     SQCKATARNL KLKYLINLET LQSAFYTEKF EVKEPGSGPS GEEIFATIII TGNGGIQWSR
     GKHKESETLT EQDLQLYCDF PNIIDVSIKQ ANQEGSNESR VVTIHKQDGK NLEIELSSLR
     EALSFVSLID GYYRLTADAH HYLCKEVAPP TVLENIQSNC HGPISMDFAI SKLKKAGNQT
     GLYVLRCSPK DFNKYFLTFA VERENVIEYK HCLITKNENE EYNLSGTKKN FSSLKDLLNC
     YQMETVRSDN IIFQFTKCCP PKPKDKSNLL VFRTNGVSDV PTSPTLQRPT HMNQMVFHKI
     RNEDLIFNES LGQGTFTKIF KGVRREVGDY GQLHETEVLL KVLDKAHRNY SESFFEAASM
     MSKLSHKHLV LNYGVCVCGD ENILVQEFVK FGSLDTYLKK NKNCINILWK LEVAKQLAWA
     MHFLEENTLI HGNVCAKNIL LIREEDRKTG NPPFIKLSDP GISITVLPKD ILQERIPWVP
     PECIENPKNL NLATDKWSFG TTLWEICSGG DKPLSALDSQ RKLQFYEDRH QLPAPKWAEL
     ANLINNCMDY EPDFRPSFRA IIRDLNSLFT PDYELLTEND MLPNMRIGAL GFSGAFEDRD
     PTQFEERHLK FLQQLGKGNF GSVEMCRYDP LQDNTGEVVA VKKLQHSTEE HLRDFEREIE
     ILKSLQHDNI VKYKGVCYSA GRRNLKLIME YLPYGSLRDY LQKHKERIDH KKLLQYTSQI
     CKGMEYLGTK RYIHRDLATR NILVENENRV KIGDFGLTKV LPQDKEYYKV KEPGESPIFW
     YAPESLTESK FSVASDVWSF GVVLYELFTY IEKSKSPPAE FMRMIGNDKQ GQMIVFHLIE
     LLKNNGRLPR PDGCPDEIYM IMTECWNNNV NQRPSFRDLA LRVDQIRDNM AG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024